Clobetasol Propionate Cream USP — Class III drug recall D-1496-2020
Terminated recall by Taro Pharmaceuticals U.S.A., Inc., reported 2020-08-19, distributed nationwide. Failed Content Uniformity: bulk lot used to make these two lots was found to have failed content uniformity.
| Recall number | D-1496-2020 |
|---|---|
| Product type | Drug |
| Classification | Class III |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Taro Pharmaceuticals U.S.A., Inc., Hawthorne, NY, United States |
| Recall initiated | 2020-07-20 |
| Classified | 2020-08-12 |
| Reported by FDA | 2020-08-19 |
| Terminated | 2023-06-20 |
| Distributed | Nationwide (US) |
| Quantity | 7,632 tubes |
| NDC | 60429-0902-15, 60429-0902-45 |
| Expiration dates | 2021-12-31 |
Product
Clobetasol Propionate Cream USP, 0.05%, a) 15 g tube, NDC: 60429-902-15; b) 45 g tube, NDC: 60429-902-45, Rx Only, For External Use Only, Not for Ophthalmic Use, Mfd by: Taro Pharmaceuticals Inc. Brampton, Ontario, Canada L6T 1C1, Marketed by: Golden State Medical Supply, Inc. Camarillo, CA 93012.
Reason for recall
Failed Content Uniformity: bulk lot used to make these two lots was found to have failed content uniformity.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1496-2020. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.